Mumbai-based Ipca Laboratories announced the acquisition of a 100 percent share capital of Pisgah Labs Inc., a North Carolina corporation, by the company's wholly owned subsidiary Ipca Pharmaceutical Inc., U.S.A., and Onyx Scientific Ltd., U.K. (Ipca Labs' wholly-owned step-down subsidiary) for $9.65 million, free of debt. Since its incorporation in...